FierceBiotech 2026年4月3日 Months after $100M series A, Syneron closes $150M round to support peptide platform
FierceBiotech 2026年4月2日 UK signs off on US pharma deal, ensuring tariff reprieve as Britain aims to reattract investments
FierceBiotech 2026年4月2日 Epia Neuro launches with BCI device to help stroke patients rework brain signals
FierceBiotech 2026年4月2日 Immunovant’s FcRn inhibitor flunks phase 3 eye disease trials, validating biotech’s waning interest
FierceBiotech 2026年4月1日 Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story
FierceBiotech 2026年4月1日 ‘There isn't as much meat left to cut’: Biopharma layoffs maintain slowdown in Q1
FierceBiotech 2026年4月1日 Oric chases Pfizer into phase 3 hailing prostate cancer edge, but investors send stock down